RhoDx
1 known investors
RhoDx develops cell-free DNA and RNA enrichment technologies for liquid biopsy cancer diagnostics. The company provides ultra-sensitive mutation detection methods to improve the performance and accessibility of liquid biopsy testing.
BiotechDigital HealthMedical Devices
Founders & leadership
CR
Charlie RodiFounder and CSO
Investors · 1
In the news
- RhoDx - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Rhodx inx: Liquid Biopsy Biotech Case Study - Liquid Biopsy Biotechcalcounselgroup.com · 2017